Neil Minkoff, MD

Articles

May 8th 2023

Clinical Considerations in the Treatment of Alopecia Areata

Neil Minkoff, MD Natasha Mesinkovska, MD Brett King, MD, PhD

Neil Minkoff; Natasha Mesinkovska, MD; and Brett King, MD, PhD discuss the diagnosis and disease assessment in alopecia areata along with clinical considerations.

April 26th 2023

Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion

Maria Lopes, MD, MS Fernando L. Pagan, MD Bhavesh Shah, RPh, BCOP Neil Minkoff, MD Sarah Jones, MPA, MS

October 20th 2022

The Promise of Telehealth—a Cautionary Tale

Neil Minkoff, MD Joshua Greenblatt, BFA Yana Volman, MBA

Implications of Telehealth Use on the Future of Oncology Care

September 15th 2022

Part I: The Promise of Telehealth – A Cautionary Tale

Neil Minkoff, MD Joshua Greenblatt, BFA Yana Volman, MBA

The rise of telehealth during COVID-19, its limitations, and its uncertain future.

May 20th 2022

Defining Value Among Treatment Options

Neil Minkoff, MD Maria Lopes, MD, MS Ayman Al-Hendy, MD, PhD Kevin U. Stephens, Sr, JD, MD Steven McCarus, MD, FACOG

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.

May 20th 2022

Evolving Treatment Strategies for UF and Endometriosis

Steven McCarus, MD, FACOG Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD Ayman Al-Hendy, MD, PhD Neil Minkoff, MD

A panel of experts discuss treatment selection among contraceptive agents and evolving treatment strategies for uterine fibroids and endometriosis.

May 6th 2022

Identifying Risk Factors For UF and Endometriosis

Steven McCarus, MD, FACOG Maria Lopes, MD, MS Ayman Al-Hendy, MD, PhD Neil Minkoff, MD Kevin U. Stephens, Sr, JD, MD

Ayman Al-Hendy, MD, PhD identifies risk factors for development of US and endometriosis.

April 29th 2022

Drivers of Healthcare Utilization in Women’s Health

Maria Lopes, MD, MS Steven McCarus, MD, FACOG Neil Minkoff, MD Kevin U. Stephens, Sr, JD, MD Ayman Al-Hendy, MD, PhD

Kevin Stephens, Sr. MD, JD examines key drivers of healthcare utilization for women of childbearing years.

April 29th 2022

A Paradigm Shift in Treatment of UF and Endometriosis

Neil Minkoff, MD Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD Ayman Al-Hendy, MD, PhD Steven McCarus, MD, FACOG

Steven McCarus, MD FACOG highlights the shift away from surgical treatment toward medical therapy in UF and endometriosis.

April 22nd 2022

Payer Considerations in Women’s Reproductive Health

Neil Minkoff, MD Ayman Al-Hendy, MD, PhD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Steven McCarus, MD, FACOG

Dr Lopes, OB-GYN and payer, discusses a focus on screening and prevention and availability of contraception among health plans in women’s health.

April 22nd 2022

Common Conditions During Reproductive Years

Neil Minkoff, MD Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD Ayman Al-Hendy, MD, PhD Steven McCarus, MD, FACOG

Ayman Al-Hendy, MD, PhD and Maria Lopes, MD, MS discuss common concerns that women seek care for during their reproductive years, including uterine fibroids, endometriosis, and unintended pregnancy.

March 28th 2022

Key Takeaways on Optimizing Glaucoma Management

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Closing out their discussion on glaucoma management, experts share practical advice for care providers and payers alike.

March 21st 2022

How Will the Glaucoma Treatment Landscape Evolve in Coming Years?

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years.

March 21st 2022

Glaucoma: Considering MIGS and Other Channel Procedures

Neil Minkoff, MD Terri-Diann Pickering, MD Nathan Radcliffe, MD Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD

Expert panelists review the use of MIGS and other channel procedures in patients with glaucoma.

March 14th 2022

Selective Laser Trabeculoplasty Use in Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option.

March 14th 2022

Novel Therapy in Glaucoma: Sustained Delivery Implants

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.

March 7th 2022

Use of Rho Kinase Inhibitors in Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Panelists discuss the role of rho kinase inhibitors in glaucoma management respective to cost, efficacy, and ease of use.

March 7th 2022

Addressing Patient Adherence in Glaucoma Management

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.

February 28th 2022

Factors Guiding Selection of Therapy for Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.

February 28th 2022

Considering Generic Vs Branded Therapy for Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.

February 21st 2022

An Overview of Treatment Options for Glaucoma

Neil Minkoff, MD Nathan Radcliffe, MD Terri-Diann Pickering, MD Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD

A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.

February 21st 2022

Glaucoma: Utilization Management and Patient Access to Therapy

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.

February 14th 2022

Goals of Therapy When Treating Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Experts highlight early detection and the goals of therapy when managing patients with glaucoma.

February 14th 2022

The Importance of Vision Preservation in Patients With Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.

February 7th 2022

Diagnosing Glaucoma: Unmet Needs and Gaps in Education

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Panelists discuss the worldwide gaps in diagnosis of glaucoma and how this negatively affects patient outcomes.

February 7th 2022

Glaucoma Risk Factors and Screening

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Shared insight on factors that put patients at risk for glaucoma and how screening can improve early diagnosis and care.

January 25th 2022

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

Robert Zivadinov, MD, PhD Michael J. Fine, MD Krishna R. Patel, PharmD, RPh Neil Minkoff, MD

January 11th 2022

Looking Toward the Future: Management of C. Diff Infection

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD

Closing out their discussion on recurrent clostridium difficile infection management, experts share closing thoughts and hopes for the future.

January 11th 2022

Evolving Medical Policies and Unmet Needs in C. Diff Infection Management

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD

Panelists review unmet needs in clostridium difficile infection management and consider how medical policies are evolving to address them.

January 4th 2022

C. Diff Infection: Patient Access to Fecal Microbiota Transplant

Neil Minkoff, MD Dale N. Gerding, MD Jessica Allegretti, MD, MPH Kevin U. Stephens, Sr, JD, MD Karina Abdallah, PharmD

Shared insight on the process to gain access to fecal microbiota transplant for patients with clostridium difficile infection.

1 2 3 4 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions